bs-10467R-Cy5.5

DATASHEET

Host: Rabbit

Target Protein: DRAK2

Immunogen Range: 281-372/372

Clonality: Polyclonal

Isotype: IgG

Entrez Gene: 9262

Swiss Prot: O94768

Source: KLH conjugated synthetic peptide derived from human DRAK2

Purification: Purified by Protein A.

Storage Buffer: Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.

Storage: Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.

Background:

Apoptosis is mediated by death domain containing adapter molecules and a caspase family of proteases. Certain serine/threonine protein kinases, such as ASK1 and RIP, are mediators of apoptosis. Two novel serine/threonine kinases that induce apoptosis were recently identified and designated DRAK1 and DRAK2 (for DAP kinase related apoptosis inducing protein kinases). DRAKs contain an N terminal kinase domain and a C terminal regulation domain. Overexpression of DRAK2 induces apoptosis. DRAKs have high sequence homology to DAP and ZIP kinases, and they represent a novel family of serine/threonine kinases, which mediates apoptosis through their catalytic activities. DRAK2 is located in nucleus and the messenger RNA was ubiquitously expressed in human tissues.

Conjugation: Cy5.5

Excitation/ Emission: 675nm/694nm

Size: 100µL

Concentration: 1ug/ul

Applications: IF(ICC)(1:50-200)
IF()

Predicted Molecular Weight: 42 kDa

Cross Reactive Species: Human
Mouse
Rat

For research use only. Not intended for diagnostic or therapeutic use.